144 related articles for article (PubMed ID: 34705247)
21. Design of benzene-1,2-diamines as selective inducible nitric oxide synthase inhibitors: a combined de novo design and docking analysis.
Francis SM; Mittal A; Sharma M; Bharatam PV
J Mol Model; 2008 Mar; 14(3):215-24. PubMed ID: 18193303
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
[TBL] [Abstract][Full Text] [Related]
23. DOWN-REGULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION BY INOSITOL HEXAPHOSPHATE IN HUMAN COLON CANCER CELLS.
Kapral M; Wawszczyk J; Sośnicki S; Węglarz L
Acta Pol Pharm; 2015; 72(4):705-11. PubMed ID: 26647627
[TBL] [Abstract][Full Text] [Related]
24. Molecular modeling and simulation approaches to characterize potential molecular targets for burdock inulin to instigate protection against autoimmune diseases.
Hashmi HF; Xuan X; Chen K; Zhang P; Shahab M; Zheng G; Younous YA; Salamatullah AM; Bourhia M
Sci Rep; 2024 May; 14(1):11291. PubMed ID: 38760355
[TBL] [Abstract][Full Text] [Related]
25. Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors.
Maldonado-Rojas W; Olivero-Verbel J
Molecules; 2012 Jul; 17(7):8118-35. PubMed ID: 22766803
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive screening and identification of natural inducible nitric oxide synthase inhibitors from Radix Ophiopogonis by off-line multi-hyphenated analyses.
Guo Y; Fu R; Qian Y; Zhou Z; Liu H; Qi J; Zhang B; Yu B
J Chromatogr A; 2019 May; 1592():55-63. PubMed ID: 30691730
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of 5-nitropyrimidine-2,4-dione analogues as inhibitors of nitric oxide and iNOS activity.
Ma L; He L; Lei L; Liang X; Lei K; Zhang R; Yang Z; Chen L
Chem Biol Drug Des; 2015 Mar; 85(3):296-9. PubMed ID: 24985766
[TBL] [Abstract][Full Text] [Related]
28. L-arginine binding to human inducible nitric oxide synthase: an antisymmetric funnel route toward isoform-specific inhibitors?
Floquet N; Hernandez JF; Boucher JL; Martinez J
J Chem Inf Model; 2011 Jun; 51(6):1325-35. PubMed ID: 21574590
[TBL] [Abstract][Full Text] [Related]
29. A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer.
Sharda S; Khandelwal R; Adhikary R; Sharma D; Majhi M; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1129-1144. PubMed ID: 31109278
[TBL] [Abstract][Full Text] [Related]
30. Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors.
Suaifan GA; Shehadehh M; Al-Ijel H; Taha MO
J Mol Graph Model; 2012 Jul; 37():1-26. PubMed ID: 22609742
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?
Tinker AC; Wallace AV
Curr Top Med Chem; 2006; 6(2):77-92. PubMed ID: 16454760
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
Chen HH; Su WC; Chou CY; Guo HR; Ho SY; Que J; Lee WY
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1093-100. PubMed ID: 16099602
[TBL] [Abstract][Full Text] [Related]
33. Withapubesides A-D: natural inducible nitric oxide synthase (iNOS) inhibitors from Physalis pubescens.
Xia GY; Yao T; Zhang BY; Li Y; Kang N; Cao SJ; Ding LQ; Chen LX; Qiu F
Org Biomol Chem; 2017 Dec; 15(47):10016-10023. PubMed ID: 29164214
[TBL] [Abstract][Full Text] [Related]
34. Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.
Gahman TC; Herbert MR; Lang H; Thayer A; Symons KT; Nguyen PM; Massari ME; Dozier S; Zhang Y; Sablad M; Rao TS; Noble SA; Shiau AK; Hassig CA
Bioorg Med Chem Lett; 2011 Nov; 21(22):6888-94. PubMed ID: 21986586
[TBL] [Abstract][Full Text] [Related]
35. Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
Grädler U; Fuchss T; Ulrich WR; Boer R; Strub A; Hesslinger C; Anézo C; Diederichs K; Zaliani A
Bioorg Med Chem Lett; 2011 Jul; 21(14):4228-32. PubMed ID: 21684157
[TBL] [Abstract][Full Text] [Related]
36. Targeting iNOS As a Valuable Strategy for the Therapy of Glioma.
Maccallini C; Gallorini M; Cataldi A; Amoroso R
ChemMedChem; 2020 Feb; 15(4):339-344. PubMed ID: 31851765
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Potential Chemical Probe as Inhibitors of CXCL12 Using Ligand-Based Virtual Screening and Molecular Dynamic Simulation.
Haider S; Barakat A; Ul-Haq Z
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092204
[TBL] [Abstract][Full Text] [Related]
38. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.
Kane AJ; Barker JE; Mitchell GM; Theile DR; Romero R; Messina A; Wagh M; Fraulin FO; Morrison WA; Stewart AG
Br J Pharmacol; 2001 Apr; 132(8):1631-8. PubMed ID: 11309233
[TBL] [Abstract][Full Text] [Related]
39. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
Cheshire DR; Åberg A; Andersson GM; Andrews G; Beaton HG; Birkinshaw TN; Boughton-Smith N; Connolly S; Cook TR; Cooper A; Cooper SL; Cox D; Dixon J; Gensmantel N; Hamley PJ; Harrison R; Hartopp P; Käck H; Leeson PD; Luker T; Mete A; Millichip I; Nicholls DJ; Pimm AD; St-Gallay SA; Wallace AV
Bioorg Med Chem Lett; 2011 Apr; 21(8):2468-71. PubMed ID: 21398123
[TBL] [Abstract][Full Text] [Related]
40. Correlation of plasma nitrite/nitrate levels and inducible nitric oxide gene expression among women with cervical abnormalities and cancer.
Sowjanya AP; Rao M; Vedantham H; Kalpana B; Poli UR; Marks MA; Sujatha M
Nitric Oxide; 2016 Jan; 52():21-8. PubMed ID: 26435258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
